Meningococcal vaccine
IMMUNISATION
The meningococcal vaccine is a vaccine that provides protection against certain strains of the bacteria Neisseria meningitidis, which can cause serious and potentially life-threatening infections such as meningitis and sepsis. Here are some basics about the meningococcal vaccine:
Route:
The meningococcal vaccine is typically administered through an injection into the muscle, usually the thigh or upper arm.
Schedule:
The recommended schedule for the meningococcal vaccine varies depending on the age and risk level of the individual:
Adolescents aged 11-12 years: a single dose of the quadrivalent meningococcal conjugate vaccine (MenACWY)
Adolescents aged 16 years: a single dose of MenACWY
Individuals aged 2 months-55 years with certain medical conditions or other risk factors: multiple doses of MenACWY or the serogroup B meningococcal vaccine (MenB) as recommended by a healthcare provider
It is important to follow the recommended schedule for the meningococcal vaccine to ensure maximum protection against the Neisseria meningitidis bacteria.
The meningococcal vaccine is very effective in preventing infection with certain strains of the Neisseria meningitidis bacteria, which can cause meningitis and sepsis. These infections are typically spread through close contact with an infected person, such as through coughing or sneezing.
In rare cases, the meningococcal vaccine may cause mild side effects such as soreness at the injection site, fever, or headache. Serious side effects are extremely rare.
In summary, the meningococcal vaccine is an important vaccine that provides protection against certain strains of the Neisseria meningitidis bacteria, which can cause serious and potentially life-threatening infections such as meningitis and sepsis. It is typically administered through an injection into the muscle, and the recommended schedule varies depending on the age and risk level of the individual. The vaccine is very effective and is particularly important for adolescents and young adults who are at increased risk of infection with the Neisseria meningitidis bacteria.